Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus

Jing‐Jing Yang, Yunzheng Yan, Qingsong Dai, Ji‐Ye Yin, Lei Zhao, Yuexiang Li, Wei Li, Wu Zhong, Ruiyuan Cao, Song LiVirologica 2022 · DOI · OpenAlex

Abstract

• Tilorone dihydrochloride possesses robust anti-SFTSV activity in vitro and in vivo. • Intraperitoneal administration of tilorone leads to protection against intracranial lethal challenge of SFTSV. • The anti-SFTSV mechanism of tilorone is through stimulation of host innate immunity. • Pre-treatment with tilorone can prevent mice from lethal SFTSV challenge.
BibTeX
@inproceedings{yang2022tilorone,
  author = {Jing‐Jing Yang and Yunzheng Yan and Qingsong Dai and Ji‐Ye Yin and Lei Zhao and Yuexiang Li and Wei Li and Wu Zhong and Ruiyuan Cao and Song Li},
  title = {{Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus}},
  booktitle = {Virologica},
  year = {2022},
  doi = {10.1016/j.virs.2022.01.014},
}

Loading related content...

Figure